Dr Bill C Sanders Jr, DDS | |
2042 Line Ave, Shreveport, LA 71104-2178 | |
(318) 425-5356 | |
(318) 674-2898 |
Full Name | Dr Bill C Sanders Jr |
---|---|
Gender | Male |
Speciality | Dentist - General Practice |
Location | 2042 Line Ave, Shreveport, Louisiana |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1073715520 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1223G0001X | Dentist - General Practice | 2008 (Louisiana) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Bill C Sanders Jr, DDS 2042 Line Ave, Shreveport, LA 71104-2178 Ph: (318) 425-5356 | Dr Bill C Sanders Jr, DDS 2042 Line Ave, Shreveport, LA 71104-2178 Ph: (318) 425-5356 |
News Archive
Rigel Pharmaceuticals, Inc. has announced the presentation of clinical data for R112, the company's lead candidate for the treatment of allergic rhinitis, during a poster session at the annual meeting of the American Academy of Allergy, Asthma and Immunology (AAAAI) in San Francisco, CA. The phase I/II single dose trial demonstrated that R112 was well tolerated and showed favorable biological effects.
Skilled Healthcare Group, Inc. today announced that five of its indirect subsidiaries that operate skilled nursing facilities in northern California have entered into an agreement to transfer their operations to Brius Healthcare, LLC and expects the transfer to be completed in April 2011 following the receipt of necessary regulatory approvals.
Sascha Drewlo, Ph.D., assistant professor of obstetrics and gynecology for the Wayne State University School of Medicine, has secured a $1.25 million grant from the National Heart, Lung and Blood Institute of the National Institutes of Health to study the role of approved drugs to improve placental function.
Envoy Therapeutics, Inc., a newly formed drug discovery company, today announced the closing of its first financing, an $8 million private placement of the company's Series A Preferred Stock. Led by 5AM Ventures, other investors participating in the financing included Takeda Research Investment and Roche Venture Fund.
Scientists have discovered a new gene mutation that causes potentially fatal swelling in unborn and newborn babies. Identifying the gene is the first step toward a future diagnostic test and targeted treatment for this condition.
› Verified 4 days ago
Dr. Jared Michael Boyd, DDS Dentist Medicare: Medicare Enrolled Practice Location: 2042 Line Ave, Shreveport, LA 71104 Phone: 318-425-5356 Fax: 318-674-2898 | |
Nadia Mohammadi, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 7251 Youree Dr, Shreveport, LA 71105 Phone: 318-239-1638 | |
Dr. Rufus Vardis Loud, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 2701 Frederick St, Shreveport, LA 71109 Phone: 318-631-3464 Fax: 318-631-3464 | |
Dr. John Eric Monsour, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 275 Kayla St, Suite 200, Shreveport, LA 71105 Phone: 318-865-4382 Fax: 318-865-4386 | |
Dr. Gregory Neil Bane, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 510 E Stoner Ave Bldg 57, Shreveport, LA 71101 Phone: 318-221-8411 | |
Dr. James Richard Brown Jr., DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 3600 North Market Street, Shreveport, LA 71107 Phone: 318-424-6405 Fax: 318-424-1599 | |
Dr. Sharon Denise Sims, D.D.S. Dentist Medicare: Medicare Enrolled Practice Location: 3546 Greenwood Rd, Shreveport, LA 71109 Phone: 318-631-1100 Fax: 318-631-1127 |